LETTER TO EDITOR
Year : 2020 | Volume
: 25 | Issue : 1 | Page : 58-
Platelet count among the patients with novel coronavirus 2019 infection: An observation on 46 cases
Sora Yasri1, Viroj Wiwanitkit2,
1 KMT Primary Care Center, Bangkok, Thailand
2 Department of Community Medicine, Dr. D. Y. Patil University, Pune, Maharashtra, India; Department of Tropical Medicine, Hainan Medical University, Haikou, China
Dr. Sora Yasri
KMT Primary Care Center, Bangkok
|How to cite this article:|
Yasri S, Wiwanitkit V. Platelet count among the patients with novel coronavirus 2019 infection: An observation on 46 cases.J Res Med Sci 2020;25:58-58
|How to cite this URL:|
Yasri S, Wiwanitkit V. Platelet count among the patients with novel coronavirus 2019 infection: An observation on 46 cases. J Res Med Sci [serial online] 2020 [cited 2020 Oct 26 ];25:58-58
Available from: https://www.jmsjournal.net/text.asp?2020/25/1/58/288694
Novel coronavirus 2019 infection is a new emerging infectious disease firstly emerged in China in December 2019. The patients usually have febrile illness with lung problem., At present, this new disease is already imported to many countries such as Thailand, therefore, it is considered as an important public health threat at present. Hematological alteration in this new disease is an interesting topic. In the previous similar emerging coronavirus infection, Middle East Respiratory Syndrome (MERS), thrombocytopenia is an important clinical problem.
Here, the authors retrospectively assessed on available data on 46 infected coronavirus cases (31 males and 15 females, aged between 25- and 74-year-old) during the 1st month of disease outbreak (December 2019 to January 2020) in China and Thailand.,, The main focused studied parameter is platelet count. Based on the analysis, the average platelet count is equal to 146.62 ± 65.75 × 109/L (min 136.93×109/L; max 156.3 × 109/L). The frequency of thrombocytopenia is 4.35%. Therefore, there is low platelet count among some patients with novel coronavirus 2019 infection. This can imply the possible similar problem of thrombocytopenia among this new coronavirus infection, similar to the previous observation in MERS.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
|1||Hsia W. Emerging new coronavirus infection in Wuhan, China: Situation in early 2020. Case Study Case Rep 2020;10:8-9.|
|2||Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.|
|3||Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Adv Trop Med Pub Health Int 2019;9:1-2.|
|4||Joob B, Wiwanitkit V. Magnitude to thrombocytopenia among the patients with novel Middle East Respiratory Syndrome. Platelets 2015;26:612.|